Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases.
Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn's disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention.
Despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.
Company Details
- Employees
- 56
- Founded
- -
- Address
- 35 Gatehouse Drive, A2, Waltham
- Phone
- (781)996-0955
- in****@****ctx.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- morphictx.com
- Keywords
- drug discovery and immunology.
- HQ
- Waltham, MA
Morphic Therapeutic Questions
Morphic Therapeutic's helpline number is (781)996-0955
Morphic Therapeutic's website is morphictx.com
Morphic Therapeutic's LinkedIn profile is https://www.linkedin.com/company/morphic-therapeutic
Morphic Therapeutic has
56 employees.
View email and phone details for 56
employees at Morphic Therapeutic.
Morphic Therapeutic's industry is
Pharmaceutical Manufacturing
Morphic Therapeutic's top competitors are
Alpine Immune Sciences, Inc.,
Morphosys,
Deciphera Pharmaceuticals,
Eli Lilly And Company,
Catalent,
Cymabay Therapeutics,
Eyebio,
Dragonfly Therapeutics, Inc.,
Longboard Pharmaceuticals,
Vertex Pharmaceuticals.
Morphic Therapeutic's support email address is info@morphictx.com
Morphic Therapeutic's categories are Pharmaceutical Manufacturing
Morphic Therapeutic's founding year is 2015
